Akoustis Technologies, Inc (NASDAQ: AKTS) reported fourth-quarter FY23 revenue growth of 60.2% year-on-year to $8.33 million, missing the consensus of $8.44 million.
Gross loss of $(1.7) million compared to a loss ...
Akoustis Technologies, Inc (NASDAQ: AKTS) reported fourth-quarter FY23 revenue growth of 60.2% year-on-year to $8.33 million, missing the consensus of $8.44 million.
Gross loss of $(1.7) million compared to a loss ...
Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS , July 15, 2024 /PRNewswire/ -- Bio-Techne Corporation ( NASDAQ : TECH) today announced that management will host a co...
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES PR Newswire MINNEAPOLIS , May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman , President and Chief Executive Officer will present at the following invest...